Loading...

<div style="overflow-x:auto;width:100%"><table class="catchall-table"><thead><tr><th style="min-width:40px">#</th><th style="min-width:240px">Event</th><th style="min-width:140px;white-space:nowrap">Stock Ticker</th><th style="min-width:140px;white-space:nowrap">Announcement Date</th><th style="min-width:140px;white-space:nowrap">Subject Company</th><th style="min-width:140px;white-space:nowrap">Revised Outlook</th><th style="min-width:140px;white-space:nowrap">Guidance Direction</th><th style="min-width:140px;white-space:nowrap">Reason</th><th style="min-width:140px;white-space:nowrap">Affected Metric</th><th style="min-width:140px;white-space:nowrap">Announcement Type</th><th style="min-width:120px;white-space:nowrap">Source</th></tr></thead><tbody><tr><td>1</td><td style="min-width:240px">CVS Group Full Year Trading Update and Cautious Outlook</td><td style="min-width:140px">LSE:CVSG</td><td style="min-width:140px">2026-07-23</td><td style="min-width:140px">CVS Group</td><td style="min-width:140px">Annual capital expenditure approximately £30 million, lower end of range. Like-for-like revenue below target.</td><td style="min-width:140px">downward</td><td style="min-width:140px">weak consumer confidence is impacting visitor numbers to its vet practices.</td><td style="min-width:140px">revenue, EBITDA, capital expenditure</td><td style="min-width:140px">trading_update</td><td style="white-space:nowrap"><a href="https://www.hl.co.uk/shares/share-research/cvs-group-fy-update-growth-fails-to-impress" target="_blank" rel="nofollow">https://www.hl.co.uk/shares/share-research/cvs-group-fy-update-growth-fails-to-impress</a></td></tr><tr><td>2</td><td style="min-width:240px">Rio Tinto Lowers Copper Cost Guidance</td><td style="min-width:140px">LSE:RIO</td><td style="min-width:140px">2026-07-15</td><td style="min-width:140px">Rio Tinto</td><td style="min-width:140px">US 30 - 50C/LB</td><td style="min-width:140px">downward</td><td style="min-width:140px">stronger by-product gold prices and improved operating efficiency</td><td style="min-width:140px">copper C1 net unit costs</td><td style="min-width:140px">earnings_guidance_revision</td><td style="white-space:nowrap"><a href="https://finimize.com/content/rbc-expects-rio-tinto-to-stick-with-its-2026-outlook" target="_blank" rel="nofollow">https://finimize.com/content/rbc-expects-rio-tinto-to-stick-with-its-2026-outlook</a></td></tr><tr><td>3</td><td style="min-width:240px">British American Tobacco Lifts Annual EPS Forecast</td><td style="min-width:140px">BATS.L</td><td style="min-width:140px">2026-07-30</td><td style="min-width:140px">British American Tobacco</td><td style="min-width:140px">full-year adjusted earnings per share growth towards the middle of its 5%-8% medium-term guidance range</td><td style="min-width:140px">upward</td><td style="min-width:140px">surging demand for its Velo nicotine pouches and a strong U.S. performance offset a sharp decline in Asia.</td><td style="min-width:140px">adjusted earnings per share (EPS)</td><td style="min-width:140px">earnings_guidance_revision</td><td style="white-space:nowrap"><a href="https://www.lse.co.uk/news/british-american-tobacco-revenue-inches-higher-reported-profit-falls-za0axapbv1i1k3o.html" target="_blank" rel="nofollow">https://www.lse.co.uk/news/british-american-tobacco-revenue-inches-higher-reported-profit-falls-za0axapbv1i1k3o.html</a></td></tr><tr><td>4</td><td style="min-width:240px">Luceco raises FY27 outlook on strong H1 trading</td><td style="min-width:140px">LON:LUCE</td><td style="min-width:140px">2026-07-28</td><td style="min-width:140px">Luceco</td><td style="min-width:140px">upgraded its outlook for 2027 above current market consensus</td><td style="min-width:140px">upward</td><td style="min-width:140px">strong first-half trading driven by a surge in its energy transition business.</td><td style="min-width:140px">revenue</td><td style="min-width:140px">trading_update</td><td style="white-space:nowrap"><a href="https://ukinvestormagazine.co.uk/luceco-next-weeks-trading-update-should-help-to-push-the-shares-now-260p-a-lot-higher-very-soon" target="_blank" rel="nofollow">https://ukinvestormagazine.co.uk/luceco-next-weeks-trading-update-should-help-to-push-the-shares-now-260p-a-lot-higher-very-soon</a></td></tr><tr><td>5</td><td style="min-width:240px">Keller Group upgrades 2026 outlook</td><td style="min-width:140px">LSE:KLR</td><td style="min-width:140px">2026-07-07</td><td style="min-width:140px">Keller Group plc</td><td style="min-width:140px">materially ahead of current market forecasts (consensus forecasts of £3.15 billion revenue and £223 million underlying EBIT)</td><td style="min-width:140px">upward</td><td style="min-width:140px">stronger-than-expected trading across the business, led by exceptional performance in North America, demand for infrastructure and data centre projects, and a record order book</td><td style="min-width:140px">revenue and underlying operating profit</td><td style="min-width:140px">earnings_guidance_revision</td><td style="white-space:nowrap"><a href="https://finimize.com/content/berenberg-sees-keller-group-beating-expectations-after-a-surprise-update" target="_blank" rel="nofollow">https://finimize.com/content/berenberg-sees-keller-group-beating-expectations-after-a-surprise-update</a></td></tr><tr><td>6</td><td style="min-width:240px">Itaconix upgrades full-year revenue guidance</td><td style="min-width:140px">LSE:ITX</td><td style="min-width:140px">2026-07-17</td><td style="min-width:140px">Itaconix</td><td style="min-width:140px">full-year 2026 revenue of at least $14.8 million, ahead of previous market forecasts of $13.3 million</td><td style="min-width:140px">upward</td><td style="min-width:140px">strong demand across its portfolio of plant-based specialty ingredients and continued growth in key international markets, record first-half sales growth</td><td style="min-width:140px">revenue</td><td style="min-width:140px">earnings_guidance_revision</td><td style="white-space:nowrap"><a href="https://uk.advfn.com/market-news/article/19744/itaconix-raises-2026-revenue-guidance-after-delivering-record-first-half-sales-growth-itx" target="_blank" rel="nofollow">https://uk.advfn.com/market-news/article/19744/itaconix-raises-2026-revenue-guidance-after-delivering-record-first-half-sales-growth-itx</a></td></tr><tr><td>7</td><td style="min-width:240px">PageGroup reports stronger Q2 gross profit</td><td style="min-width:140px">LSE:PAGE</td><td style="min-width:140px">2026-07-13</td><td style="min-width:140px">PageGroup</td><td style="min-width:140px">stronger-than-expected second-quarter gross profit</td><td style="min-width:140px">upward</td><td style="min-width:140px">growth across the Americas and Asia-Pacific helping offset weaker conditions in Europe and the UK.</td><td style="min-width:140px">gross profit</td><td style="min-width:140px">trading_update</td><td style="white-space:nowrap"><a href="https://londoninsider.co.uk/ftse-100-holds-steady-as-u-s-strikes-on-iran-send-oil-prices-sharply-higher-page-megp-plus" target="_blank" rel="nofollow">https://londoninsider.co.uk/ftse-100-holds-steady-as-u-s-strikes-on-iran-send-oil-prices-sharply-higher-page-megp-plus</a></td></tr><tr><td>8</td><td style="min-width:240px">BP revises guidance with $1 billion impairment</td><td style="min-width:140px">BP.L</td><td style="min-width:140px">2026-07-14</td><td style="min-width:140px">BP</td><td style="min-width:140px">around $1 billion of impairments</td><td style="min-width:140px">downward</td><td style="min-width:140px">primarily related to its lower-carbon energy transition businesses</td><td style="min-width:140px">impairments</td><td style="min-width:140px">earnings_guidance_revision</td><td style="white-space:nowrap"><a href="https://www.reuters.com/business/energy/bp-expects-upstream-output-fall-second-quarter-line-with-guidance-2026-07-14" target="_blank" rel="nofollow">https://www.reuters.com/business/energy/bp-expects-upstream-output-fall-second-quarter-line-with-guidance-2026-07-14</a></td></tr><tr><td>9</td><td style="min-width:240px">Wickes Group PLC Q2 Trading Update</td><td style="min-width:140px">LSE:WIX</td><td style="min-width:140px">2026-07-21</td><td style="min-width:140px">Wickes Group PLC</td><td style="min-width:140px">analyst consensus of £55.4 million for adjusted pre-tax profit</td><td style="min-width:140px">maintained</td><td style="min-width:140px">continued volume growth across the business and increased customer numbers</td><td style="min-width:140px">adjusted pre-tax profit</td><td style="min-width:140px">trading_update</td><td style="white-space:nowrap"><a href="https://www.proactiveinvestors.com/companies/news/1095756/wickes-highlights-q2-revenue-growth-though-diy-broadly-flat-update-1095756.html" target="_blank" rel="nofollow">https://www.proactiveinvestors.com/companies/news/1095756/wickes-highlights-q2-revenue-growth-though-diy-broadly-flat-update-1095756.html</a></td></tr><tr><td>10</td><td style="min-width:240px">Experian Issues Trading Update, Maintains Full-Year Guidance</td><td style="min-width:140px">LSE:EXPN</td><td style="min-width:140px">2026-07-16</td><td style="min-width:140px">Experian</td><td style="min-width:140px">adjusted, or organic sales for the full year of 6-8%, potentially driving another year of double-digit growth in adjusted earnings</td><td style="min-width:140px">maintained</td><td style="min-width:140px">hindered by subdued credit card activity</td><td style="min-width:140px">sales</td><td style="min-width:140px">trading_update</td><td style="white-space:nowrap"><a href="https://finimize.com/content/morgan-stanley-sees-experian-starting-fy27-on-solid-footing" target="_blank" rel="nofollow">https://finimize.com/content/morgan-stanley-sees-experian-starting-fy27-on-solid-footing</a></td></tr><tr class="row-locked"><td>11</td><td style="min-width:240px">Creo Medical maintains FY26 revenue guidance</td><td style="min-width:140px">LSE: CREO</td><td style="min-width:140px">2026-07-29</td><td style="min-width:140px">Creo Medical</td><td style="min-width:140px">50%-60% revenue growth this year</td><td style="min-width:140px">maintained</td><td style="min-width:140px">A strong order book and continued international expansion, strategic reset and operational improvements</td><td style="min-width:140px">revenue growth</td><td style="min-width:140px">trading_update</td><td style="white-space:nowrap"><a href="https://www.thebusinessdesk.com/south-west/news/44379-strong-growth-forecast-for-medical-device-firm-on-a-mission-to-transform-cancer-surgery" target="_blank" rel="nofollow">https://www.thebusinessdesk.com/south-west/news/44379-strong-growth-forecast-for-medical-device-firm-on-a-mission-to-transform-cancer-surgery</a></td></tr><tr class="row-locked"><td>12</td><td style="min-width:240px">Victrex maintains full-year profit guidance after strong Q3</td><td style="min-width:140px">VCT</td><td style="min-width:140px">2026-07-07</td><td style="min-width:140px">Victrex</td><td style="min-width:140px">between £42 million and £44 million for the full year</td><td style="min-width:140px">maintained</td><td style="min-width:140px">strong third-quarter revenue growth, demand from aerospace and electronics sectors, and progress with profit improvement programme including cost savings</td><td style="min-width:140px">underlying pre-tax profit</td><td style="min-width:140px">trading_update</td><td style="white-space:nowrap"><a href="https://uk.advfn.com/market-news/article/19041/victrex-keeps-full-year-outlook-unchanged-after-strong-third-quarter-revenue-growth-vct" target="_blank" rel="nofollow">https://uk.advfn.com/market-news/article/19041/victrex-keeps-full-year-outlook-unchanged-after-strong-third-quarter-revenue-growth-vct</a></td></tr></tbody></table></div>